The Patent Finder

Zora Biosciences Oy

23 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 3 fees due Dec 2 to 9, 2026 · next Dec 2
  • 1 fee due Jun 1, 2027
    The maintenance fee for Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients (US 9,201,080) comes due Jun 1, 2027. Unpaid by Dec 1, 2027, it lapses early.
  • 1 fee due Jul 14, 2027
    The maintenance fee for Methods for detecting ovarian cancer (US 10,534,001) comes due Jul 14, 2027. Unpaid by Jan 14, 2028, it lapses early.
  • 1 fee due Aug 4, 2027
    The maintenance fee for Lipidomic Biomarkers for Atherosclerosis and Cardiovascular Disease (US 10,551,394) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
  • 1 fee due Sep 26, 2027
    The maintenance fee for Ceramides and Their Use in Diagnosing CVD (US 11,940,453) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,046,538Lipidomic Biomarkers for Atherosclerosis and Cardiovascular Disease
In force
 · High confidence
In forceHigh confidence
US 9,052,327Lipidomic Biomarkers for the Prediction of Cardiovascular Outcomes in Coronary Artery Disease Patients Undergoing Statin Treatment
In force
 · High confidence
In forceHigh confidence
US 9,052,328Lipidomic Biomarkers for the Prediction of Cardiovascular Outcomes in Coronary Artery Disease Patients Not Undergoing Statin Treatment
In force
 · High confidence
In forceHigh confidence
US 9,201,080Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients
In force
 · High confidence
In forceHigh confidence
US 9,423,406Lipidomic Biomarkers for the Prediction of Cardiovascular Outcomes in Coronary Artery Disease Patients Not Undergoing Statin Treatment
In force
 · High confidence
In forceHigh confidence
US 9,459,264Lipidomic Biomarkers for Atherosclerosis and Cardiovascular Disease
In force
 · High confidence
In forceHigh confidence
US 9,459,265Lipidomic Biomarkers for the Prediction of Cardiovascular Outcomes in Coronary Artery Disease Patients Undergoing Statin Treatment
In force
 · High confidence
In forceHigh confidence
US 9,841,431Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients
In force
 · High confidence
In forceHigh confidence
US 9,857,386Lipidomic Biomarkers for Atherosclerosis and Cardiovascular Disease
In force
 · High confidence
In forceHigh confidence
US 9,863,965Lipidomic Biomarkers for the Prediction of Cardiovascular Outcomes in Coronary Artery Disease Patients Not Undergoing Statin Treatment
In force
 · High confidence
In forceHigh confidence
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
Also on record, not counted in the 23: 3 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 8 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited